After Hours Summary: WWD +16.6%, ZI +5.5%, NXPI +4.2% up on earnings; BB +8.5% up on strategic review of its businesses; CHGG -32.3%, ANET -7.6%, SYK -5.3% down on earningsAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: WWD +16.6%, SFM +7.1%, SIBN +6.2%, FLS +5.9%, ZI +5.5%, TEX +5.3%, NXPI +4.2%, LEG +3.6%, VNOM +2.9%, AMRC +2.4%, TMDX +2.4%, SON +2.1%, PDM +1.8%, AMKR +1.5%, LSCC +1.1%, MSTR +1.1%, KIDS +1%, MSA +0.7%, AL +0.6%, MGM +0.6%, HOLX +0.4%, RIG +0.2%, CF +0.2%, NSA +0.1%, FCPT +0.1%, VICI +0.1%
Companies trading higher in after hours in reaction to news: BB +8.5% (considering strategic alternatives for its businesses), CHEF +3.8% (acquires Hardie's Fresh Foods and Greenlead Produce & Specialty Foods), EDIT +2.3% (study of SLEEK published), BOC +1.9% (increases ownership to 100% in 24th Street Asset Management), WTRG +1.6% (subsidiary acquires wastewater system), DDD +1% (acquiring Wematter), ADSE +0.4% (delaying filing 20-F), NOG +0.2% (increases dividend)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: CHGG -32.3%, ETWO -17.2%, CYH -12.9%, ANET -7.6%, MED -7.6%, CACC -6.8%, CNO -6.3%, AXNX -6.2%, SYK -5.3%, SGRY -4.2%, RE -3.5%, RMBS -2.7%, VRTX -1.7%, FANG -1.7%, ADUS -1.6%, JJSF -1%, CAR -0.9%, FMC -0.6%, VRNS -0.3%, SYM -0.3%, SBAC -0.1%, INST -0.1%, SCI -0.1%
Companies trading lower in after hours in reaction to news: TVTX -24.8% (topline primary efficacy results from Phase 3 DUPLEX study), MLTX -2.2% (files mixed shelf), CIFR -1.4% (announces April 2023 production), SPWR -0.9% (appoints new COO), TMUS -0.1% (files mixed shelf; files stock offering)
- S&P Global US Manufacturing final April print of 50.2, down from 50.4 flash, up from 49.2 in March - highest since Oct 2022
- ISM US Manufacturing April print of 47.1, up from 46.3 prior (and betyer than the expected 46.8) - but still in contraction (sub-50).
“US manufacturing output has regained some encouraging momentum at the start of the second quarter, having stabilised in March after four months of decline.“While the upturn is in part linked to greatly improved supply chains, helping reduce backlogs of orders, April also saw a welcome upturn in new order inflows for the first time since last September.“Although only modest, the rise in new orders hints at a tentative revival of demand, notably from consumers but there are also signs that fewer customers are deliberately winding down their inventory levels.“The brightening demand picture was accompanied by a lifting of business confidence about the outlook and increased hiring. The downside was a reigniting of inflationary pressures, with a stronger order book encouraging more firms to pass through higher costs to customers.”
“Of the six biggest manufacturing industries, two - Petroleum & Coal Products; and Transportation Equipment - registered growth in April."“New order rates remain sluggish as panelists remain concerned about when manufacturing growth will resume. Panelists’ comments registered a 1-to-1 ratio regarding optimism for future growth and continuing near-term demand declines. Supply chains are prepared and eager for growth, as panelists’ comments support reduced lead times for their more important purchases. Price instability remains and future demand is uncertain as companies continue to work down overdue deliveries and backlogs. Seventy-three percent of manufacturing gross domestic product (GDP) is contracting, up from 70 percent in March.However, fewer industries contracted strongly; the proportion of manufacturing GDP with a composite PMI® calculation at or below 45 percent — a good barometer of overall manufacturing weakness — was 12 percent in April, compared to 25 percent in March,” says Fiore.
Research Calls
- Upgrades:
- Alignment Healthcare (ALHC) upgraded to Outperform from Mkt Perform at Raymond James; tgt $9
- Allbirds (BIRD) upgraded to Outperform from Market Perform at Telsey Advisory Group; tgt $1.50
- AvalonBay (AVB) upgraded to Neutral from Underweight at Piper Sandler; tgt raised to $193
- Banco Bilbao Vizcaya Argentaria (BBVA) upgraded to Buy from Hold at HSBC Securities
- Biogen (BIIB) upgraded to Buy from Neutral at Guggenheim; tgt raised to $350
- Carter Bank & Trust (CARE) upgraded to Outperform from Mkt Perform at Raymond James; tgt $17
- Comcast (CMCSA) upgraded to Buy from Neutral at BofA Securities; tgt raised to $49
- General Motors (GM) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt raised to $38
- IAMGOLD (IAG) upgraded to Outperform from Market Perform at BMO Capital Markets; tgt raised to $3.25
- Logitech Int'l SA (LOGI) upgraded to Equal-Weight from Underweight at Morgan Stanley; tgt raised to $56
- Manitowoc (MTW) upgraded to Equal Weight from Underweight at Wells Fargo; tgt raised to $17
- Otis Worldwide (OTIS) upgraded to Equal Weight from Underweight at Wells Fargo; tgt raised to $88
- Scotts Miracle-Gro (SMG) upgraded to Buy from Hold at Stifel; tgt raised to $80
- Teradata (TDC) upgraded to Buy from Neutral at Guggenheim; tgt $62
- Zillow (ZG) upgraded to Mkt Perform from Underperform at Bernstein; tgt raised to $45
- Downgrades:
- ArcBest (ARCB) downgraded to Underperform from Neutral at BofA Securities; tgt lowered to $91
- Banco Santander (SAN) downgraded to Hold from Buy at HSBC Securities
- Doximity (DCOS) downgraded to Equal Weight from Overweight at Wells Fargo; tgt lowered to $37
- Exxon Mobil (XOM) downgraded to Neutral from Buy at Goldman; tgt $125
- IVERIC bio (ISEE) downgraded to Neutral from Buy at Guggenheim
- Principal Fincl (PFG) downgraded to Neutral from Buy at BofA Securities; tgt lowered to $78
- South Atlantic Bancshares (SABK) downgraded to Neutral from Buy at Janney; tgt lowered to $14
- Valley National (VLY) downgraded to Mkt Perform from Strong Buy at Raymond James
- Others:
- Danaher (DHR) initiated with an Outperform at SVB Securities; tgt $300
- Edgewise Therapeutics (EWTX) initiated with a Buy at Truist
- Endeavor Group (EDR) initiated with a Buy at Guggenheim; tgt $33
- Immunovant Sciences (IMVT) initiated with a Buy at BofA Securities; tgt $26
- MoonLake Immunotherapeutics (MLTX) initiated with a Buy at Guggenheim; tgt $51
- TD Synnex (SNX) initiated with a Buy at Goldman; tgt $101
- Treace Medical Concepts (TMCI) initiated with a Buy at Truist; tgt $33


